Literature DB >> 8132786

Formation of non-cyclooxygenase-derived prostanoids (F2-isoprostanes) in plasma and low density lipoprotein exposed to oxidative stress in vitro.

S M Lynch1, J D Morrow, L J Roberts, B Frei.   

Abstract

F2-isoprostanes are prostaglandin F2-like compounds that are known to be formed in vivo by free radical oxidation of arachidonyl-containing lipids, and their plasma levels have been suggested as indicators of in vivo oxidative stress. As oxidation of LDL, a likely causal factor in atherosclerosis, involves lipid peroxidation, we investigated whether F2-isoprostanes are formed in plasma and LDL exposed to oxidative stress, and how F2-isoprostane formation is related to endogenous antioxidant status. In plasma exposed to aqueous peroxyl radicals, lipid hydroperoxides and esterified F2-isoprostanes were formed simultaneously after endogenous ascorbate and ubiquinol-10 had been exhausted, despite the continued presence of urate, alpha-tocopherol, beta-carotene, and lycopene. In isolated LDL exposed to aqueous peroxyl radicals or Cu2+, consumption of endogenous ubiquinol-10 and alpha-tocopherol was followed by rapid formation and subsequent breakdown of lipid hydroperoxides and esterified F2-isoprostanes, and a continuous increase in LDL's electronegativity, indicative of atherogenic modification. In Cu(2+)-exposed LDL, the decrease in esterified F2-isoprostane levels was paralleled by the appearance of free F2-isoprostanes, suggesting that hydrolysis by an LDL-associated activity had occurred. Our data suggest that F2-isoprostanes are useful markers of LDL oxidation in vivo. As F2-isoprostanes are potent vasoconstrictors and can modulate platelet aggregation, their formation in LDL demonstrated here may also have important implications for the etiology of cardiovascular disease.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8132786      PMCID: PMC294019          DOI: 10.1172/JCI117107

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  48 in total

Review 1.  Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity.

Authors:  D Steinberg; S Parthasarathy; T E Carew; J C Khoo; J L Witztum
Journal:  N Engl J Med       Date:  1989-04-06       Impact factor: 91.245

2.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

3.  Low density lipoprotein undergoes oxidative modification in vivo.

Authors:  W Palinski; M E Rosenfeld; S Ylä-Herttuala; G C Gurtner; S S Socher; S W Butler; S Parthasarathy; T E Carew; D Steinberg; J L Witztum
Journal:  Proc Natl Acad Sci U S A       Date:  1989-02       Impact factor: 11.205

4.  Single vertical spin density gradient ultracentrifugation.

Authors:  B H Chung; J P Segrest; M J Ray; J D Brunzell; J E Hokanson; R M Krauss; K Beaudrie; J T Cone
Journal:  Methods Enzymol       Date:  1986       Impact factor: 1.600

Review 5.  The pathogenesis of atherosclerosis--an update.

Authors:  R Ross
Journal:  N Engl J Med       Date:  1986-02-20       Impact factor: 91.245

6.  Macrophage oxidation of low density lipoprotein generates a modified form recognized by the scavenger receptor.

Authors:  S Parthasarathy; D J Printz; D Boyd; L Joy; D Steinberg
Journal:  Arteriosclerosis       Date:  1986 Sep-Oct

7.  Evaluation of an isoluminol chemiluminescence assay for the detection of hydroperoxides in human blood plasma.

Authors:  B Frei; Y Yamamoto; D Niclas; B N Ames
Journal:  Anal Biochem       Date:  1988-11-15       Impact factor: 3.365

8.  Monocytes and neutrophils oxidize low density lipoprotein making it cytotoxic.

Authors:  M K Cathcart; D W Morel; G M Chisolm
Journal:  J Leukoc Biol       Date:  1985-08       Impact factor: 4.962

9.  Iron and copper promote modification of low density lipoprotein by human arterial smooth muscle cells in culture.

Authors:  J W Heinecke; H Rosen; A Chait
Journal:  J Clin Invest       Date:  1984-11       Impact factor: 14.808

10.  Antioxidant defenses and lipid peroxidation in human blood plasma.

Authors:  B Frei; R Stocker; B N Ames
Journal:  Proc Natl Acad Sci U S A       Date:  1988-12       Impact factor: 11.205

View more
  26 in total

Review 1.  Ascorbic acid: chemistry, biology and the treatment of cancer.

Authors:  Juan Du; Joseph J Cullen; Garry R Buettner
Journal:  Biochim Biophys Acta       Date:  2012-06-20

2.  Localization of distinct F2-isoprostanes in human atherosclerotic lesions.

Authors:  D Praticò; L Iuliano; A Mauriello; L Spagnoli; J A Lawson; J Rokach; J Maclouf; F Violi; G A FitzGerald
Journal:  J Clin Invest       Date:  1997-10-15       Impact factor: 14.808

3.  Altered arachidonic acid metabolism in urate crystal induced inflammation.

Authors:  A Margalit; K L Duffin; A F Shaffer; S A Gregory; P C Isakson
Journal:  Inflammation       Date:  1997-04       Impact factor: 4.092

4.  An improved GC/MS-based procedure for the quantitation of the isoprostane 15-F2t-IsoP in rat plasma.

Authors:  C E Parker; L B Graham; M N Nguyen; B C Gladen; M B Kadiiska; J C Barrett; K B Tomer
Journal:  Mol Biotechnol       Date:  2001-06       Impact factor: 2.695

5.  Urinary F2-isoprostane metabolite levels in children with sleep-disordered breathing.

Authors:  Hawley E Montgomery-Downs; Jyoti Krishna; L Jackson Roberts; David Gozal
Journal:  Sleep Breath       Date:  2006-12       Impact factor: 2.816

6.  Synthesis of 8-epi-prostaglandin F2alpha by human endothelial cells: role of prostaglandin H2 synthase.

Authors:  M T Watkins; G M Patton; H M Soler; H Albadawi; D E Humphries; J E Evans; H Kadowaki
Journal:  Biochem J       Date:  1999-12-15       Impact factor: 3.857

Review 7.  Reciprocal regulation of the nitric oxide and cyclooxygenase pathway in pathophysiology: relevance and clinical implications.

Authors:  Daniela Salvemini; Sangwon F Kim; Vincenzo Mollace
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2013-02-06       Impact factor: 3.619

8.  Nocturnal change of circulating intercellular adhesion molecule 1 levels in children with snoring.

Authors:  Athanasios G Kaditis; Emmanouel I Alexopoulos; Efthimia Kalampouka; Fotini Hatzi; Ioanna Karadonta; Theodoros Kyropoulos; Dimitrios G Kaditis; Konstantinos Gourgoulianis; George A Syrogiannopoulos
Journal:  Sleep Breath       Date:  2007-12       Impact factor: 2.816

Review 9.  Preventive and Therapeutic Potential of Vitamin C in Mental Disorders.

Authors:  Qian-Qian Han; Tian-Tian Shen; Fang Wang; Peng-Fei Wu; Jian-Guo Chen
Journal:  Curr Med Sci       Date:  2018-03-15

10.  Increased urinary 15-F2t-isoprostane concentrations in patients with non-ischaemic congestive heart failure: a marker of oxidative stress.

Authors:  M Nonaka-Sarukawa; K Yamamoto; H Aoki; H Takano; T Katsuki; U Ikeda; K Shimada
Journal:  Heart       Date:  2003-08       Impact factor: 5.994

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.